Okumi Masayoshi, Okabe Yasuhiro, Unagami Kohei, Kakuta Yoichi, Iizuka Junpei, Takagi Toshio, Shirakawa Hiroki, Shimizu Tomokazu, Omoto Kazuya, Ishida Hideki, Nakamura Masafumi, Tanabe Kazunari
Department of Urology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku, Tokyo, 162-8666, Japan.
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Clin Exp Nephrol. 2019 Aug;23(8):1066-1075. doi: 10.1007/s10157-019-01737-2. Epub 2019 Apr 24.
The interaction between post-transplant anemia (PTA) and allograft function in kidney transplantation has not been evaluated directly. PTA, defined by WHO/AST criteria, was investigated in 1307 adult kidney transplant recipients between 2000 and 2015 (median follow-up, 7 years).
We investigated the impact of hemoglobin (Hb) on graft failure (non-censored for death) and their interactions, time-dependent Cox model, and subgroup analysis were used.
PTA prevalence was 43.6% at 7 years and varied according to allograft function, recipient sex, and follow-up period. Decreased Hb considering the time-varying effect was associated with an increased risk of graft failure (hazard ratio = 1.83, 95% CI 1.66-2.02, P < 0.001). In subgroup analysis, allograft function (post-transplant time-averaged estimated glomerular filtration rate and cut point: 45 mL/min/1.73 m) had significant interaction (P = 0.032). The 7-year graft failure rate in recipients with PTA and high eGFR was 7.7% (HR 1.52, 95% CI 1.25-1.84), whereas in those with PTA and low eGFR was 19.9% (HR 2.00, 95% CI 1.74-2.31).
The unfavorable impact of PTA was significantly enhanced by low allograft function. PTA is likely to be associated with graft failure due to interaction with allograft function. Therefore, we should consider both Hb level and allograft function while determining the treatment strategy.
肾移植中移植后贫血(PTA)与同种异体移植功能之间的相互作用尚未得到直接评估。根据世界卫生组织/美国移植学会(WHO/AST)标准定义的PTA,在2000年至2015年期间对1307例成年肾移植受者进行了调查(中位随访时间为7年)。
我们研究了血红蛋白(Hb)对移植失败(未因死亡而删失)的影响及其相互作用,采用了时间依赖性Cox模型和亚组分析。
7年时PTA患病率为43.6%,并根据同种异体移植功能、受者性别和随访时间而有所不同。考虑到时间变化效应的Hb降低与移植失败风险增加相关(风险比=1.83,95%置信区间1.66-2.02,P<0.001)。在亚组分析中,同种异体移植功能(移植后时间平均估计肾小球滤过率及切点:45 mL/min/1.73 m²)有显著的相互作用(P=0.032)。PTA且估算肾小球滤过率(eGFR)高的受者7年移植失败率为7.7%(风险比1.52,95%置信区间1.25-1.84),而PTA且eGFR低的受者为19.9%(风险比2.00,95%置信区间1.74-2.31)。
同种异体移植功能低下显著增强了PTA的不利影响。PTA可能由于与同种异体移植功能的相互作用而与移植失败相关。因此,在确定治疗策略时,我们应同时考虑Hb水平和同种异体移植功能。